Dr. Veronica Rizalla

Recommended Articles

• Woman Hits Hole-in-One After Fifth Breast Cancer Operation

  Breast cancer patients often find rehabilitation and recovery to be a long, arduous process. It can be hard to get back into a normal routine after going through the countless chemotherapy sessions and surgeries that often come with cancer rehabilitation. One survivor from Old Hickory, Tennessee set...

• Fat-Soluble Vitamins Could Help Fight Cystic Fibrosis

  Doctors and medical professionals in recent years have prescribed numerous antibiotics to cystic fibrosis patients in order to counteract Burkholderia cenocepacia, bacteria that are known to cause lung infections in those with cystic fibrosis.It has become apparent in recent years that these...

• Head Motions Offer Insight into Autism for Girls

  Autism was always considered to be a boy’s disorder. Girls are diagnosed with autism, too, but at a much lower rate; five times as many boys are diagnosed with autism as are girls.That may not necessarily be because boys have autism more frequently than girls, though. It is possible that girls...

• Track Your Baby's Development Week by Week in the Second Trimester

  Growth and development happens swiftly during the second trimester. The baby continues to change and develop almost daily.During this stage, the focus of development is to increase in size and weight. In addition, the umbilical cord continues to thicken as it carries nutrients to the fetus. The baby...

• What to Avoid If You Have Lyme Disease

  If you get Lyme disease, it may be necessary to make a change in your lifestyle, particularly your diet, in order to make the treatment time shorter. As you probably already know, lyme disease cannot be cured. What can be done is to treat the symptoms of the disease. To quicken the recovery process,...

• Breaking News on the Treatment of Follicular Lymphoma

  Reuters, the international news agency out of London, has announced that the FDA has given a new drug “accelerated approval,” for the treatment of follicular lymphoma.The drug, Aliqopa (copanlisib), showed complete or partial shrinkage of tumors in 59% of study participants during drug studies,...